Alerts will be sent to your verified email
Verify Email
OMKARPH
|
Omkar Pharmachem
|
Adeshwar Meditex
|
Hamps Bio
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.16 % | 6.79 % | 14.19 % |
|
5yr Avg Net Profit Margin
|
-77.87 % | 2.51 % | 5.23 % |
|
Price to Book
|
2.76 | 0.0 | 2.73 |
|
P/E
|
145.63 | 11.65 | 81.15 |
|
5yr Avg Cash Conversion Cycle
|
60.23 Days | 155.96 Days | 74.76 Days |
|
5yr Average Interest Coverage Ratio
|
3.51 | 2.12 | 3.45 |
|
5yr Avg ROCE
|
1.5 % | 15.02 % | 18.02 % |
|
5yr Avg Operating Profit Margin
|
-57.26 % | 7.0 % | 14.19 % |
|
5 yr average Debt to Equity
|
0.08 | 0.75 | 0.99 |
|
5yr CAGR Net Profit
|
n/a | -1.06 % | 20.11 % |
|
5yr Average Return on Assets
|
1.11 % | 2.78 % | 6.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.03 % | 57.55 % | 71.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.9 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Omkar Pharmachem
|
Adeshwar Meditex
|
Hamps Bio
|
|---|